Search Results - "Lemstrova, R"

Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216 by Mohelnikova-Duchonova, B, Kocik, M, Duchonova, B, Brynychova, V, Oliverius, M, Hlavsa, J, Honsova, E, Mazanec, J, Kala, Z, Ojima, I, Hughes, D J, Doherty, J E, Murray, H A, Crockard, M A, Lemstrova, R, Soucek, P

“…The Hedgehog pathway is one of the major driver pathways in pancreatic ductal adenocarcinoma. This study investigated prognostic importance of Hedgehog…”
Get full text

1164P Changes of TCR repertoire in metastatic melanoma and renal cell carcinoma patients treated with nivolumab correlate with overall survival by Klabusay, M., Lemstrova, R., Skácel, J.

Get full text

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma by Obazee, O., Archibugi, L., Andriulli, A., Soucek, P., Małecka‐Panas, E., Ivanauskas, A., Johnson, T., Gazouli, M., Pausch, T., Lawlor, R. T., Cavestro, G. M., Milanetto, A. C., Di Leo, M., Pasquali, C., Hegyi, P., Szentesi, A., Radu, C. E., Gheorghe, C., Theodoropoulos, G. E., Bergmann, F., Brenner, H., Vodickova, L., Katzke, V., Campa, D., Strobel, O., Kaiser, J., Pezzilli, R., Federici, F., Mohelnikova‐Duchonova, B., Boggi, U., Lemstrova, R., Johansen, J. S., Bojesen, S. E., Chen, I., Jensen, B. V., Capurso, G., Pazienza, V., Dervenis, C., Sperti, C., Mambrini, A., Hackert, T., Kaaks, R., Basso, D., Talar‐Wojnarowska, R., Maiello, E., Izbicki, J. R., Cuk, K., Saum, K. U., Cantore, M., Kupcinskas, J., Palmieri, O., Delle Fave, G., Landi, S., Salvia, R., Fogar, P., Vashist, Y. K., Scarpa, A., Vodicka, P., Tjaden, C., Iskierka‐Jazdzewska, E., Canzian, F.

“…Rare truncating BRCA2 K3326X (rs11571833) and pathogenic CHEK2 I157T (rs17879961) variants have previously been implicated in familial pancreatic ductal…”
Get full text

Role of solute carrier transporters in pancreatic cancer: a review by Lemstrová, Radmila, Souček, Pavel, Melichar, Bohuslav, Mohelnikova-Duchonova, Beatrice

“…Nucleoside analogs such as gemcitabine and 5-fluorouracil are currently the cornerstone of chemotherapy in patients with pancreatic ductal adenocarcinoma…”
Get more information

Appendiceal tumors and pseudomyxoma peritonei: current recommendations for clinical practice by Klos, D, Riško, J, Hanuliak, J, Loveček, M, Mohelníková-Duchoňová, B, Lemstrová, R, Tučková, L, Melichar, B

“…Appendiceal tumors and pseudomyxoma peritonei (PMP) are rare tumors. Perforated epithelial tumors of the appendix are the most common source of PMP. This…”
Get more information